STOCK TITAN

Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Viatris (NASDAQ: VTRS), a global healthcare company, announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, in Miami Beach, Florida. CEO Scott A Smith and other executives will represent the company in a scheduled fireside chat at 9:20 a.m. ET.

Interested parties can access a live webcast of the event at the company’s investor relations website, with an archived version available post-event for a time.

Positive
  • Viatris's participation in a high-profile conference may increase visibility and investor interest.
  • Opportunity for executives to communicate strategic initiatives and company performance to investors.
Negative
  • No new financial or clinical data announced, which may not provide immediate value to investors.
  • Participation in conferences alone might not substantially impact stock performance without new information.

PITTSBURGH, June 4, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference at the Loews Miami Beach Hotel in Miami Beach, Florida on Tuesday, June 11, 2024. Chief Executive Officer Scott A Smith and Company executives will represent the company in a fireside chat scheduled at 9:20 a.m. ET.

Interested parties can access a live webcast of the event at investor.viatris.com. An archived version also will be available following the live event and can be accessed at the same location for a limited time. 

About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India.  Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X (formerly Twitter).

Viatris OUS Logo (PRNewsfoto/Viatris Inc.)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-participate-in-the-goldman-sachs-45th-annual-global-healthcare-conference-302162439.html

SOURCE Viatris Inc.

FAQ

What event will Viatris participate in on June 11, 2024?

Viatris will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024.

Who will represent Viatris at the Goldman Sachs Annual Global Healthcare Conference?

CEO Scott A Smith and other company executives will represent Viatris.

How can interested parties access the Viatris event at the Goldman Sachs Healthcare Conference?

Interested parties can access a live webcast of the event at investor.viatris.com.

Will there be an archived version of the Viatris webcast from the Goldman Sachs conference?

Yes, an archived version will be available at the same location following the live event for a time.

Viatris Inc.

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Stock Data

14.66B
1.19B
0.41%
82.85%
1.74%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
CANONSBURG